New Key Statistics Module, Z-Score and F-Score
NAS:VBIV Key Ratios
| Market Cap $ M | 18.84 |
| Enterprise Value $ M | 47.62 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.05 |
| Price/Sales | 1.34 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 8.00 |
| EPS (TTM) $ | -9.41 |
| Beneish M-Score | 13.61 |
| 10-y EBITDA Growth Rate % | 17.60 |
| 5-y EBITDA Growth Rate % | 20.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.56 |
| EV-to-EBITDA | -0.58 |
| PEG | -- |
| Shares Outstanding M | 28.68 |
| Net Margin (%) | -1,069.29 |
| Operating Margin % | -637.11 |
| Pre-tax Margin (%) | -1,069.29 |
| Quick Ratio | 0.37 |
| Current Ratio | 0.48 |
| ROA % (ttm) | -82.95 |
| ROE % (ttm) | -319.38 |
| ROIC % (ttm) | -59.11 |
| Dividend Yield % | -- |
| Altman Z-Score | -12.90 |
VBIV Number of Guru Trades
VBIV Volume of Guru Trades
Gurus Latest Trades with NAS:VBIV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VBIV is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
VBI Vaccines Inc Insider Transactions
No Available Data
News about NAS:VBIV
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers